Results 71 to 80 of about 24,353 (179)

Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies

open access: yes
Objective. Sensory neuropathies (SNs) are often classified as idiopathic even if immunological mechanisms can be suspected. Antibodies against the intracellular domain of the fibroblast growth factor receptor 3 (FGFR3) possibly identify a subgroup of SN ...
Reynaud-Federspiel, Evelyne   +11 more
core   +1 more source

miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression

open access: yesJournal of Immunology Research, 2018
Our previous studies showed that Fibroblast growth factor receptor 3 (FGFR3) contributed to cell growth in lung cancer. However, the correlation between FGFR3 and tumor progression, coupled with the underlying mechanisms, are not fully understood.
Pengyu Jing   +9 more
doaj   +1 more source

Genetic testing in paediatric neurological disorders

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In this study 390 paediatric patients with neurological disorders underwent genetic testing via exome sequencing, commercial panel, in‐house epilepsy, and movement disorder gene panels. Exome sequencing provides the highest diagnostic yield, and severe developmental delay and hypotonia predicted pathogenic variants in the exome sequencing cohort ...
Wafa Bani Uraba   +15 more
wiley   +1 more source

Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis

open access: yes, 2009
Objectives: The fibroblast growth factor receptor 3 gene ( FGFR3) plays a critical role in cartilage growth-plate differentiation and bony development.
Hung, Chia-Cheng; Lee, Chien-Nan; Chang, Chien-Hui; Jong, Yuh-Jyh; Chen, Chih-Ping; Hsieh, Wu-Shiun; Su, Yi-Ning; Lin, Win-Li   +1 more
core  

FGFR3 Mutations in Benign Skin Tumors

open access: yes, 2006
Activating FGFR3 germline mutations cause skeletal dysplasia and craniosynostosis syndromes. Somatic FGFR3 mutations have been identified in several cancer entities such as urothelial carcinoma and multiple myeloma.
Thomas Vogt   +5 more
core   +1 more source

FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma

open access: yes, 2022
Oncogenic fusion genes have emerged as successful targets in several malignancies, such as chronic myeloid leukemia and lung cancer. Fusion of the fibroblast growth receptor 3 and the transforming acidic coiled coil containing protein—FGFR3-TACC3 fusion ...
Hanna Gött   +3 more
core   +1 more source

Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody

open access: yesDisease Models & Mechanisms, 2016
Activating mutations in fibroblast growth factor receptor 3 (FGFR3) have been identified in multiple types of human cancer and in congenital birth defects.
Yongjun Yin   +12 more
doaj   +1 more source

Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing

open access: yes, 2012
John M Millholland, Shuqiang Li, Cecilia A Fernandez, Anthony P ShuberPredictive Biosciences Inc, Lexington, MA, USAAbstract: Biological fluid-based noninvasive biomarker assays for monitoring and diagnosing disease are clinically powerful.
Shuber AP   +4 more
core  

FGFR3 can tyrosine phosphorylate TAK1.

open access: yes, 2014
(A) HEK293 cells transfected with FGFR3K508M or FGFR3K650E. Twenty-four hours following transfection, cells were lysed and TAK1 immunoprecipitated from 1 mg total lysate.
Matthew Hallowell (513742)   +8 more
core   +1 more source

Hybrid grading systems improve progression risk stratification in non‐invasive papillary urothelial carcinoma and support a histomorphological continuum of disease progression

open access: yesHistopathology, EarlyView.
Hybrid grading systems significantly improve progression‐risk stratification in non‐invasive papillary urothelial carcinoma compared with the WHO 2004/2016 binary classification, with most benefit achieved by a Hybrid 3‐Tier framework. These findings support the existence of a histomorphological continuum of progression risk within the conventional ...
Jane K Nguyen   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy